Maintaining confidentiality of emerging results in COVID-19 vaccine trials is essential
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2020 |
|---|---|
| Erschienen: |
2020 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:396 |
|---|---|
| Enthalten in: |
Lancet (London, England) - 396(2020), 10263 vom: 21. Nov., Seite 1611-1613 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Krause, Philip R [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
COVID-19 Vaccines |
|---|
| Anmerkungen: |
Date Completed 30.11.2020 Date Revised 10.11.2023 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1016/S0140-6736(20)32259-5 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM316944238 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM316944238 | ||
| 003 | DE-627 | ||
| 005 | 20231225162200.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2020 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/S0140-6736(20)32259-5 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1056.xml |
| 035 | |a (DE-627)NLM316944238 | ||
| 035 | |a (NLM)33125926 | ||
| 035 | |a (PII)S0140-6736(20)32259-5 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Krause, Philip R |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Maintaining confidentiality of emerging results in COVID-19 vaccine trials is essential |
| 264 | 1 | |c 2020 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 30.11.2020 | ||
| 500 | |a Date Revised 10.11.2023 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Research Support, Non-U.S. Gov't | |
| 650 | 7 | |a COVID-19 Vaccines |2 NLM | |
| 650 | 7 | |a Viral Vaccines |2 NLM | |
| 700 | 1 | |a Fleming, Thomas R |e verfasserin |4 aut | |
| 700 | 1 | |a Ellenberg, Susan S |e verfasserin |4 aut | |
| 700 | 1 | |a Henao-Restrepo, Ana Maria |e verfasserin |4 aut | |
| 700 | 0 | |a WHO Ad Hoc Clinical Trial Expert Group |e verfasserin |4 aut | |
| 700 | 1 | |a Krause, P R |e investigator |4 oth | |
| 700 | 1 | |a Fleming, T |e investigator |4 oth | |
| 700 | 1 | |a Alejandria, M M |e investigator |4 oth | |
| 700 | 1 | |a Bhargava, B |e investigator |4 oth | |
| 700 | 1 | |a Ellenberg, S |e investigator |4 oth | |
| 700 | 1 | |a Garcia, P J |e investigator |4 oth | |
| 700 | 1 | |a Halloran, E |e investigator |4 oth | |
| 700 | 1 | |a Henao-Restrepo, A M |e investigator |4 oth | |
| 700 | 1 | |a Longini, I |e investigator |4 oth | |
| 700 | 1 | |a Miranda Montoya, M C |e investigator |4 oth | |
| 700 | 1 | |a Roses, M |e investigator |4 oth | |
| 700 | 1 | |a Sommerfelt, H |e investigator |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |t Lancet (London, England) |d 1945 |g 396(2020), 10263 vom: 21. Nov., Seite 1611-1613 |w (DE-627)NLM000473936 |x 1474-547X |7 nnns |
| 773 | 1 | 8 | |g volume:396 |g year:2020 |g number:10263 |g day:21 |g month:11 |g pages:1611-1613 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/S0140-6736(20)32259-5 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 396 |j 2020 |e 10263 |b 21 |c 11 |h 1611-1613 | ||